November 13, 2009 – 11:48 am
I know, I know – we’re all too busy, no time to read etc – but here are a few articles from recent times that are worth the effort, if you haven’t spotted them already. They cover everything from the health impacts of inequality to mental health, alcohol policy, and the ties that bind pharma [...]
By Croakey
|
Posted in Health inequalities, Journal articles, Media-related issues, alcohol, conflicts of interest, global health, health & medical marketing, health and medical education, pharmaceutical industry, public health
|
Also tagged alcohol, High Court, inequality, mental illness, violence
|
October 13, 2009 – 9:04 pm
As mentioned recently, Pfizer is hitting the consumer and medical media in the interests of its combination heart pill, Caduet.
Regular readers may remember that earlier this year Michele Kosky, executive director of the Health Consumers’ Council in WA, asked the TGA and Medicines Australia to investigate whether the consumer advertisement breaches the ban on direct-to-consumer [...]
September 22, 2009 – 3:14 pm
The organisers of a forum on pharmaceutical regulation, to be held in Adelaide on Thursday, are promising a “robust discussion”. I hope there are plans for a podcast as I’m sure there will be plenty of interest in the debate.
Healthy Skepticism is hosting the panel discussion, at the Women and Children’s Hospital, to examine questions [...]
Professor Garry Jennings, Director of the Baker IDI Heart & Diabetes Institute, has responded to recent Croakey posts raising concerns about his organisation’s close ties with industry. It seems there will be no more Baker staff appearing in pharmaceutical advertorials. He writes:
“The Croakey posting on Conflict of Interest points to both the diversity of views [...]
Following the recent post about the Baker IDI Heart and Diabetes Institute’s latest foray into pharmaceutical marketing, Croakey asked both the Baker and the NHMRC for comment.
No word yet from the Baker, but Professor Warwick Anderson, ceo of the NHMRC, sent this comment:
“The Australian Code for the Responsible Conduct of Research (issued jointly by NHMRC, [...]
The Crikey Register of Influence – which details links between opinion leaders, organisations and industry marketing campaigns – has been updated.
The new entries are Professor Simon Stewart, Head, Preventive Cardiology at the Baker IDI Heart and Diabetes Institute, and his colleague, Dr Melinda Carrington, General Manager of the Baker’s Disease Management and Preventative Programs.
They appeared [...]
Further to the post below re Ken Harvey’s concerns about Sigma, cruises, and product promotion….the ceo of the Generic Medicines Industry Association, Kate Lynch, has advised Harvey that:
“…under the requirements of the Therapeutic Goods Act (1989), the Therapeutic Goods Advertising Code (2007) and as stipulated in the Therapeutic Good Administration’s letter of marketing approval, Sponsor [...]
Sue Dunlevy did this story about Sigma, a generic drug manufacturer, wanting to take GPs and pharmacists on a luxury cruise visiting Italy, Malta, Corsica and Monte Carlo. Former Victorian premier Jeff Kennett is billed as the keynote speaker at the conference advertised in the Australian Doctor magazine. The story was also picked up here.
Dr [...]
When the NHMRC convened a workshop on conflicts of interest in Canberra recently, participants were told that Australia had been slower than some other countries to take steps to minimise the impact of such conflicts upon research and clinical practice.
In the piece below, Sydney dermatologist Dr Chris Commens argues that unless the medical profession smartens [...]
The controversial sponsorship deal between Sanofi-Aventis and the Baker IDI Heart and Diabetes Institute has been found to be in breach of the Medicines Australia code of conduct.
Under the deal, for every Plavix script dispensed through retail pharmacy in 2009, Sanofi-Aventis agreed to donate 25 cents to support the Baker’s medical research and preventative health [...]
